{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:53:52Z","timestamp":1791644032650,"version":"4.3.4"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Fifth Batch of Hospital Key Discipline Construction Projects","award":["2022YYZDXK01"],"award-info":[{"award-number":["2022YYZDXK01"]}]},{"name":"Fujian Clinical Medical Research Center for Cardiac Macrovascular Diseases","award":["2021YGPT002"],"award-info":[{"award-number":["2021YGPT002"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Increasing evidences indicate that systemic inflammation plays a significant role of adverse prognosis in patients with coronary heart disease (CHD). The inflammatory burden index (IBI) is a novel biomarker that reflects systemic inflammation. The aim of this study was to investigate the association between IBI and prognosis of CHD patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>In this retrospective analysis, data from 2453 CHD patients enrolled from December 2017 to December 2022.IBI was defined as neutrophil\/lymphocyte*C-reactive protein, with patients categorized into four groups based on quartiles of baseline IBI levels. The primary outcome was adverse cardiovascular and cerebrovascular events (MACCEs) occurring during hospitalization, which included repeat revascularization, new-onset atrial fibrillation (NOAF), stroke, and all-cause in-hospital mortality. Multivariate logistic regression models and restricted cubic spline (RCS) analysis were used to investigate the association between IBI and prognosis of CHD patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>High levels of IBI were associated with higher risk of MACCEs, especially when IBI\u2009\u2265\u200945.68, patients exhibited a higher risk of MACCEs (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). After adjusting for baseline confounders, multivariate logistic regression analysis demonstrated that baseline IBI was an independent predictor for NOAF (Odds Ratio (OR): 2.05; 95% confidence interval (CI): 1.30\u20133.24; <jats:italic>P<\/jats:italic>\u2009=\u20090.002) and contrast-induced nephropathy (CIN) (OR: 1.95; 95%CI: 1.16\u20133.28; <jats:italic>P<\/jats:italic>\u2009=\u20090.012) in CHD patients, mainly driven by the highest quartile. In addition, RCS confirmed a linear relationship between IBI and NOAF (<jats:italic>P<\/jats:italic> for non-linear\u2009=\u20090.425) and a nonlinear relationship with CIN (<jats:italic>P<\/jats:italic> for non-linear\u2009=\u20090.032).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>IBI is a promising biomarker of systemic inflammation in CHD patients, where higher IBI levels are associated with adverse prognosis. These findings may aid clinicians in precise decision-making to improve outcomes in patients with CHD.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0325287","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T17:22:56Z","timestamp":1751908976000},"page":"e0325287","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Association between inflammatory burden index and prognosis in patients with coronary heart disease: A retrospective study"],"prefix":"10.1371","volume":"20","author":[{"given":"Wen","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baolin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangwan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8953-7549","authenticated-orcid":true,"given":"Yanjuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"issue":"8","key":"pone.0325287.ref001","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association","volume":"149","author":"SS Martin","year":"2024","journal-title":"Circulation"},{"issue":"25","key":"pone.0325287.ref002","first-page":"2982","article-title":"Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study","volume":"76","author":"GA Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"pone.0325287.ref003","first-page":"2529","article-title":"The Global Burden of Cardiovascular Diseases and Risk Factors: 2020 and Beyond","volume":"74","author":"GA Mensah","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"pone.0325287.ref004","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/0003319719887655","article-title":"Fasting blood glucose and HbA1c correlate with severity of coronary artery disease in elective PCI patients with HbA1c 5.7% to 6.4","volume":"71","author":"J Yang","year":"2020","journal-title":"Angiology"},{"issue":"10","key":"pone.0325287.ref005","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1016\/j.celrep.2018.05.010","article-title":"Obesity and insulin resistance promote atherosclerosis through an IFN\u03b3-regulated macrophage protein network","volume":"23","author":"CA Reardon","year":"2018","journal-title":"Cell Rep"},{"issue":"19","key":"pone.0325287.ref006","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/eurheartj\/ehu505","article-title":"Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective","volume":"36","author":"T Jernberg","year":"2015","journal-title":"Eur Heart J"},{"issue":"5","key":"pone.0325287.ref007","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1253\/circj.CJ-15-0167","article-title":"Modulation of autoimmunity and atherosclerosis - common targets and promising translational approaches against disease","volume":"79","author":"DFJ Ketelhuth","year":"2015","journal-title":"Circ J"},{"issue":"17","key":"pone.0325287.ref008","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.jacc.2018.08.1043","article-title":"Inflammation, immunity, and infection in atherothrombosis: JACC review topic of the week","volume":"72","author":"P Libby","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"pone.0325287.ref009","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and inflammation in atherosclerosis","volume":"124","author":"D Wolf","year":"2019","journal-title":"Circ Res"},{"issue":"1","key":"pone.0325287.ref010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis","volume":"119","author":"SD Prabhu","year":"2016","journal-title":"Circ Res"},{"key":"pone.0325287.ref011","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.atherosclerosis.2018.07.014","article-title":"Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions","volume":"276","author":"P Raggi","year":"2018","journal-title":"Atherosclerosis"},{"issue":"23","key":"pone.0325287.ref012","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","article-title":"Inflammation in atherosclerosis: from pathophysiology to practice","volume":"54","author":"Leducq Transatlantic Network on Atherothrombosis","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"pone.0325287.ref013","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/clinchem\/hvaa275","article-title":"Inflammation in atherosclerosis-no longer a theory","volume":"67","author":"P Libby","year":"2021","journal-title":"Clin Chem"},{"issue":"11","key":"pone.0325287.ref014","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11883-020-00883-3","article-title":"Targeting inflammation to reduce residual cardiovascular risk","volume":"22","author":"ON Ajala","year":"2020","journal-title":"Curr Atheroscler Rep"},{"issue":"9","key":"pone.0325287.ref015","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.3390\/biomedicines11092444","article-title":"C-reactive protein: the quintessential marker of systemic inflammation in coronary artery disease-advancing toward precision medicine","volume":"11","author":"E Amezcua-Castillo","year":"2023","journal-title":"Biomedicines"},{"issue":"3","key":"pone.0325287.ref016","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae050","article-title":"Associations between inflammatory and angiogenic proteomic biomarkers, and cardiovascular events and mortality in relation to kidney function","volume":"17","author":"B Salzinger","year":"2024","journal-title":"Clin Kidney J"},{"issue":"6","key":"pone.0325287.ref017","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.tcm.2022.02.005","article-title":"Myocardial ischemia-reperfusion injury and the influence of inflammation","volume":"33","author":"M Algoet","year":"2023","journal-title":"Trends Cardiovasc Med"},{"issue":"6","key":"pone.0325287.ref018","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.clnu.2022.04.019","article-title":"Inflammatory burden as a prognostic biomarker for cancer","volume":"41","author":"H Xie","year":"2022","journal-title":"Clin Nutr"},{"issue":"7","key":"pone.0325287.ref019","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1159\/000535727","article-title":"Clinical significance of the preoperative inflammatory burden index in esophageal cancer","volume":"102","author":"C Yin","year":"2024","journal-title":"Oncology"},{"issue":"4","key":"pone.0325287.ref020","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3390\/cancers16040828","article-title":"Prognostic value of inflammatory burden index in advanced gastric cancer patients undergoing multimodal treatment","volume":"16","author":"Z Pelc","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"2","key":"pone.0325287.ref021","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clnu.2023.01.005","article-title":"The inflammatory burden index: a promising prognostic predictor in patients with locally advanced gastric cancer","volume":"42","author":"P Ding","year":"2023","journal-title":"Clin Nutr"},{"key":"pone.0325287.ref022","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.2147\/JIR.S416295","article-title":"inflammatory burden index: association between novel systemic inflammatory biomarkers and prognosis as well as in-hospital complications of patients with aneurysmal subarachnoid hemorrhage","volume":"16","author":"Z Song","year":"2023","journal-title":"J Inflamm Res"},{"key":"pone.0325287.ref023","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.2147\/JIR.S419087","article-title":"Association between inflammatory burden index and unfavorable prognosis after endovascular thrombectomy in acute ischemic stroke","volume":"16","author":"M Du","year":"2023","journal-title":"J Inflamm Res"},{"key":"pone.0325287.ref024","volume-title":"The Complete Official Codebook: ICD-10-CM","author":"American Medical Association","year":"2016"},{"issue":"7","key":"pone.0325287.ref025","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1093\/cvr\/cvad038","article-title":"Pyruvate dehydrogenase kinase regulates vascular inflammation in atherosclerosis and increases cardiovascular risk","volume":"119","author":"MJ Forteza","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"1","key":"pone.0325287.ref026","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41392-022-00955-7","article-title":"Inflammation and atherosclerosis: signaling pathways and therapeutic intervention","volume":"7","author":"P Kong","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"pone.0325287.ref027","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3390\/biomedicines10081850","article-title":"Neutrophils and neutrophil extracellular traps in cardiovascular disease: an overview and potential therapeutic approaches","volume":"10","author":"K Shirakawa","year":"2022","journal-title":"Biomedicines"},{"issue":"2","key":"pone.0325287.ref028","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIRCRESAHA.116.304072","article-title":"Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction","volume":"116","author":"U Hofmann","year":"2015","journal-title":"Circ Res"},{"issue":"9","key":"pone.0325287.ref029","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/eurheartj\/ehaa1034","article-title":"The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials","volume":"42","author":"NH Adamstein","year":"2021","journal-title":"Eur Heart J"},{"issue":"18","key":"pone.0325287.ref030","doi-asserted-by":"crossref","first-page":"14378","DOI":"10.3390\/ijms241814378","article-title":"Assessment of inflammatory hematological ratios (NLR, PLR, MLR, LMR and monocyte\/hdl-cholesterol ratio) in acute myocardial infarction and particularities in young patients","volume":"24","author":"B-S Tudurachi","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0325287.ref031","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/biomedicines11010076","article-title":"FIB-4 index and neutrophil-to-lymphocyte-ratio as death predictor in coronary artery disease patients","volume":"11","author":"M Gaggini","year":"2022","journal-title":"Biomedicines"},{"issue":"12","key":"pone.0325287.ref032","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1373\/clinchem.2011.169839","article-title":"C-reactive protein induces release of both endothelial microparticles and circulating endothelial cells in vitro and in vivo: further evidence of endothelial dysfunction","volume":"57","author":"S Devaraj","year":"2011","journal-title":"Clin Chem"},{"issue":"4","key":"pone.0325287.ref033","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/cvr\/cvz301","article-title":"Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction","volume":"116","author":"LSF Konijnenberg","year":"2020","journal-title":"Cardiovasc Res"},{"key":"pone.0325287.ref034","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.2147\/JIR.S411086","article-title":"Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are important indicators for predicting in-hospital death in elderly AMI patients","volume":"16","author":"Y Chen","year":"2023","journal-title":"J Inflamm Res"},{"key":"pone.0325287.ref035","doi-asserted-by":"crossref","first-page":"705862","DOI":"10.3389\/fcvm.2021.705862","article-title":"Association of derived neutrophil-to-lymphocyte ratio with prognosis of coronary heart disease after PCI","volume":"8","author":"G-Q Liu","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"pone.0325287.ref036","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12872-020-01500-6","article-title":"Preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with major adverse cardiovascular and cerebrovascular events in coronary heart disease patients undergoing non-cardiac surgery","volume":"20","author":"J Larmann","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"issue":"6","key":"pone.0325287.ref037","first-page":"4188","article-title":"Serum C reactive protein and procalcitonin are valuable predictors of coronary heart disease and poor prognosis in the elderly","volume":"15","author":"L Yu","year":"2023","journal-title":"Am J Transl Res"},{"key":"pone.0325287.ref038","article-title":"The prognostic value of hematologic inflammatory markers in patients with acute coronary syndrome undergoing percutaneous coronary intervention","volume":"28","author":"W Fan","year":"2022","journal-title":"Clin Appl Thromb Hemost"},{"issue":"3","key":"pone.0325287.ref039","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1536\/ihj.19-543","article-title":"Neutrophil to lymphocyte ratio and long-term cardiovascular outcomes in coronary artery disease patients with low high-sensitivity C-reactive protein level","volume":"61","author":"H Wada","year":"2020","journal-title":"Int Heart J"},{"key":"pone.0325287.ref040","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.2147\/JIR.S428734","article-title":"Discordance between neutrophil to lymphocyte ratio and high sensitivity C-reactive protein to predict clinical events in patients with stable coronary artery disease: a large-scale cohort study","volume":"16","author":"J He","year":"2023","journal-title":"J Inflamm Res"},{"issue":"1","key":"pone.0325287.ref041","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.numecd.2023.10.006","article-title":"Association between inflammatory burden index and all-cause mortality in the general population aged over 45 years: Data from NHANES 2005-2017","volume":"34","author":"C He","year":"2024","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"pone.0325287.ref042","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijcard.2017.07.022","article-title":"Association of sST2 and hs-CRP levels with new-onset atrial fibrillation in coronary artery disease","volume":"248","author":"S Nortamo","year":"2017","journal-title":"Int J Cardiol"},{"issue":"10","key":"pone.0325287.ref043","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2217\/bmm-2020-0838","article-title":"Systemic immune-inflammation index predicts new-onset atrial fibrillation after ST elevation myocardial infarction","volume":"15","author":"A Ba\u011fc\u0131","year":"2021","journal-title":"Biomark Med"},{"issue":"4","key":"pone.0325287.ref044","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/joa3.12077","article-title":"Inflammation and atrial fibrillation: a comprehensive review","volume":"34","author":"P Korantzopoulos","year":"2018","journal-title":"J Arrhythm"},{"issue":"9","key":"pone.0325287.ref045","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCRESAHA.114.302226","article-title":"Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression","volume":"114","author":"J Heijman","year":"2014","journal-title":"Circ Res"},{"issue":"6","key":"pone.0325287.ref046","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.116.023163","article-title":"Modifiable risk factors and atrial fibrillation","volume":"136","author":"DH Lau","year":"2017","journal-title":"Circulation"},{"issue":"1","key":"pone.0325287.ref047","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00702.2020","article-title":"Coronary heart disease and atrial fibrillation: a vicious cycle","volume":"320","author":"F Liang","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"pone.0325287.ref048","doi-asserted-by":"crossref","first-page":"118379","DOI":"10.1016\/j.lfs.2020.118379","article-title":"Advances in the pathogenesis and prevention of contrast-induced nephropathy","volume":"259","author":"F Zhang","year":"2020","journal-title":"Life Sci"},{"issue":"2","key":"pone.0325287.ref049","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cjca.2015.05.013","article-title":"Contrast-induced nephropathy: from pathophysiology to preventive strategies","volume":"32","author":"L Azzalini","year":"2016","journal-title":"Can J Cardiol"},{"issue":"8","key":"pone.0325287.ref050","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3390\/toxics12080620","article-title":"Unveiling the mysteries of contrast-induced acute kidney injury: new horizons in pathogenesis and prevention","volume":"12","author":"Z Wang","year":"2024","journal-title":"Toxics"},{"issue":"1","key":"pone.0325287.ref051","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s40001-024-01782-y","article-title":"Evaluating biomarkers for contrast-induced nephropathy following coronary interventions: an umbrella review on meta-analyses","volume":"29","author":"A Mahapatro","year":"2024","journal-title":"Eur J Med Res"},{"issue":"12","key":"pone.0325287.ref052","article-title":"Correlation of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) with contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary interventions","volume":"12","author":"K Butt","year":"2020","journal-title":"Cureus"},{"key":"pone.0325287.ref053","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ebiom.2016.05.017","article-title":"Limb ischemic preconditioning protects against contrast-induced nephropathy via renalase","volume":"9","author":"F Wang","year":"2016","journal-title":"EBioMedicine"},{"key":"pone.0325287.ref054","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ebiom.2017.02.009","article-title":"Antithrombin III protects against contrast-induced nephropathy","volume":"17","author":"Z Lu","year":"2017","journal-title":"EBioMedicine"},{"issue":"12","key":"pone.0325287.ref055","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41581-024-00875-5","article-title":"Lymphocytes and innate immune cells in acute kidney injury and repair","volume":"20","author":"K Lee","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"pone.0325287.ref056","doi-asserted-by":"crossref","first-page":"729084","DOI":"10.3389\/fphys.2021.729084","article-title":"Lymphocytes: versatile participants in acute kidney injury and progression to chronic kidney disease","volume":"12","author":"C Cao","year":"2021","journal-title":"Front Physiol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0325287","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T17:23:05Z","timestamp":1751908985000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0325287"}},"subtitle":[],"editor":[{"given":"Chiara","family":"Lazzeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":56,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0325287","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]}}}